AC Immune SA
NASDAQ:ACIU
AC Immune SA
NASDAQ:ACIU
Price:
4.62 USD
-4.35%
Updated:
Jun 5, 2024
AC Immune SA
Retained Earnings
|
AC Immune SA
Retained Earnings Peer Comparison
Comparables:
ADCT
CRSP
BSLN
IDIA
KURN
Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AC Immune SA
NASDAQ:ACIU
|
Retained Earnings
-CHf332.6m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Retained Earnings
-$1.3B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Retained Earnings
-$1.1B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Retained Earnings
CHf41.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-6%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Retained Earnings
-CHf3.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Retained Earnings
CHf53.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
See Also
What is AC Immune SA's Retained Earnings?
Retained Earnings
-332.6m
CHF
-332.6m
CHF
Based on the financial report for Mar 31, 2024, AC Immune SA's Retained Earnings amounts to -332.6m CHF.
What is AC Immune SA's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-42%
-42%
Over the last year, the Retained Earnings growth was -19%. The average annual Retained Earnings growth rates for AC Immune SA have been -31% over the past three years , -42% over the past five years .
You don't have any saved screeners yet
